The Drug-Induced Respiratory Disease Website
The development of ICPI-related ILD may negatively impact the outcome in lung cancer patients
Publications
Suresh K, Voong KR, Shankar B, Forde PM, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, D'Alessio F, Hales RK, Lin CT, Psoter KJ, Danoff SK, Naidoo J
Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018 Dec;13;1930-1939 — 2018 Dec — 1930-1939
Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, Grob JJ, Cowey CL, Lao CD, Wagstaff J, Schadendorf D, Ferrucci PF, Smylie M, Dummer R, Hill A, Hogg D, Haanen J, Carlino MS, Bechter O, Maio M, Marquez-Rodas I, Guidoboni M, McArthur G, Lebbé C, Asci
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
The New England journal of medicine 2017 10 05;377;1345-1356 — 2017 10 05 — 1345-1356
Delaunay M, Cadranel J, Lusque A, Meyer N, Gounant V, Moro-Sibilot D, Michot JM, Raimbourg J, Girard N, Guisier F, Planchard D, Metivier AC, Tomasini P, Dansin E, Pérol M, Campana M, Gautschi O, Früh M, Fumet JD, Audigier-Valette C, Couraud S, Dalle S, Le
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients.
The European respiratory journal 2017 08;50; — 2017 08
Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Trials.
Chest 2017 08;152;271-281 — 2017 08 — 271-281
Pulmonary Infiltrates in a Patient With Advanced Melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Mar;35;705-708 — 2017 Mar — 705-708
Naidoo J, Wang X, Woo KM, Iyriboz T, Halpenny D, Cunningham J, Chaft JE, Segal NH, Callahan MK, Lesokhin AM, Rosenberg J, Voss MH, Rudin CM, Rizvi H, Hou X, Rodriguez K, Albano M, Gordon RA, Leduc C, Rekhtman N, Harris B, Menzies AM, Guminski AD, Carlino
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Mar;35;709-717 — 2017 Mar — 709-717
Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a meta-analysis.
Therapeutic advances in respiratory disease 2016 06;10;183-93 — 2016 06 — 183-93
Nishino M, Chambers ES, Chong CR, Ramaiya NH, Gray SW, Marcoux JP, Hatabu H, Jänne PA, Hodi FS, Awad MM
Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.
Cancer immunology research 2016 Apr;4;289-93 — 2016 Apr — 289-93
Radiologic manifestations of immune-related adverse events in patients with metastatic melanoma undergoing anti-CTLA-4 antibody therapy.
AJR. American journal of roentgenology 2011 Dec;197;W992-W1000 — 2011 Dec — W992-W1000